Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy,Annals of Clinical and Translational Neurology

当前位置： X-MOL 学术 › Ann. Clin. Transl. Neur. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy
Annals of Clinical and Translational Neurology ( IF 4.4 ) Pub Date : 2021-08-28 , DOI: 10.1002/acn3.51417
Charlotte Lilien _{1,

2} , Harmen Reyngoudt _{1,

3} , Andreea Mihaela Seferian ₁ , Teresa Gidaro ₁ , Mélanie Annoussamy _{1,

4} , Virginie Chê ₁ , Valérie Decostre ₁ , Isabelle Ledoux ₁ , Julien Le Louër _{1,

3} , Eric Guemas ₅ , Francesco Muntoni _{6,

7} , Jean-Yves Hogrel ₁ , Pierre Georges Carlier _{1,

8} , Laurent Servais _{1,

2,

9} ,

Affiliation

To understand the natural disease upper limb progression over 3 years of ambulatory and non-ambulatory patients with Duchenne muscular dystrophy (DMD) using functional assessments and quantitative magnetic resonance imaging (MRI) and to exploratively identify prognostic factors.

中文翻译：